Literature DB >> 31626785

Mechanisms of Itch in Stasis Dermatitis: Significant Role of IL-31 from Macrophages.

Takashi Hashimoto1, Christina Dorothy Kursewicz2, Rachel Alison Fayne2, Sonali Nanda2, Serena Maya Shah2, Leigh Nattkemper2, Hiroo Yokozeki3, Gil Yosipovitch4.   

Abstract

Stasis dermatitis (SD) is a common disease in the elderly population, with pruritus being one of the troublesome symptoms. However, there are few therapeutic modalities available for SD-associated itch because little is known about its pathophysiological mechanism. Therefore, we sought to investigate the mediators of itch in SD using an immunofluorescence study on patient lesions focusing on IL-31. Ex vivo stimulation studies using murine peritoneal macrophages were also used to elucidate the pathological mechanisms of the generation of IL-31. In SD lesions, dermal infiltrating IL-31(+) cells were increased in number compared with the healthy controls, and the majority of IL-31(+) cells were CD68(+) macrophages. The presence of itch in SD was significantly associated with the amount of CD68(+)/IL-31(+) macrophages and CD68(+)/CD163(+) M2 macrophages. The number of CD68(+)/IL-31(+) macrophages was correlated with the number of dermal C-C chemokine receptor type 4(+) T helper type 2 cells, IL-17(+) cells, basophils, substance P(+) cells, and dermal deposition of periostin and hemosiderin. Furthermore, murine peritoneal macrophages expressed an M2 marker arginase-1 and generated IL-31 when stimulated with a combination of substance P, periostin, and red blood cell lysate (representing hemosiderin). IL-31 from macrophages may play a role in itch in SD.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31626785     DOI: 10.1016/j.jid.2019.09.012

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  THE SKIN MICROBIOTA AND ITCH: Is There a Link?

Authors:  Hei Sung Kim; Gil Yosipovitch
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

Review 2.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

3.  Dermal Periostin: A New Player in Itch of Prurigo Nodularis.

Authors:  Takashi Hashimoto; Leigh A Nattkemper; Hei Sung Kim; Christina D Kursewicz; Emilie Fowler; Serena M Shah; Sonali Nanda; Rachel A Fayne; Paolo Romanelli; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2021-01-20       Impact factor: 3.875

Review 4.  Interleukin-31 as a Clinical Target for Pruritus Treatment.

Authors:  Kenji Kabashima; Hiroyuki Irie
Journal:  Front Med (Lausanne)       Date:  2021-02-12

Review 5.  Interleukin-31 and Pruritic Skin.

Authors:  Masutaka Furue; Mihoko Furue
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

Review 6.  Connections between Immune-Derived Mediators and Sensory Nerves for Itch Sensation.

Authors:  Sumika Toyama; Mitsutoshi Tominaga; Kenji Takamori
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

Review 7.  The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development.

Authors:  Kazufumi Kunimura; Yoshinori Fukui
Journal:  Int Immunol       Date:  2021-11-25       Impact factor: 4.823

8.  High Serum IL-31 Concentration Is Associated with Itch among Renal Transplant Recipients.

Authors:  Piotr K Krajewski; Kinga Tyczyńska; Klaudia Bardowska; Piotr Olczyk; Danuta Nowicka-Suszko; Dariusz Janczak; Hanna Augustyniak-Bartosik; Magdalena Krajewska; Jacek C Szepietowski
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

Review 9.  The Skin Microbiota and Itch: Is There a Link?

Authors:  Hei Sung Kim; Gil Yosipovitch
Journal:  J Clin Med       Date:  2020-04-22       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.